NEW YORK, September 28, 2015 /PRNewswire/ --
.ACI Association has initiated research coverage on the
following equities: BioTelemetry, Inc. (NASDAQ: BEAT),
ABIOMED, Inc. (NASDAQ: ABMD), CytRx Corporation
(NASDAQ: CYTR), Dynavax Technologies Corporation (NASDAQ:
DVAX), EnteroMedics Inc. (NASDAQ: ETRM). On Friday, September 25, 2015, Nasdaq ended at
4686.50, down 1.01%, Dow Jones advanced 0.70%, to finish the day at
16314.67, and the S&P closed at 1931.34, down 0.05%. Register
for your complimentary reports at the links given below.
--
BioTelemetry Inc
--
BioTelemetry Inc's stock edged lower by 6.09% to close Friday's
session at USD 12.80. The company's
shares oscillated between USD 12.69 and USD
13.68. The stock recorded a trading volume of 0.79 million
shares, which was above its 50-day daily average volume of 0.52
million shares. Over the last three days, BioTelemetry Inc's shares
have declined by 10.99% and in the past one week it has moved down
14.27%. However, over the last three months, the stock has gained
32.64% and in the past six months, the shares have picked up
40.66%. Further, the company is trading at a price to book ratio of
5.15. The historical PB ratio is near to 4.20. Additionally, the
stock is trading at a price to cash flow ratio of 17.09 and price
to sales ratio of 1.98. Sign up and read the free notes on BEAT at:
http://www.aciassociation.com/BEAT.pdf
--
Abiomed Inc
--
The stock of Abiomed Inc lost 2.44% to close Friday's session at
USD 95.11. The shares of the company
moved in the range of USD 93.38 and
USD 99.26. A trading volume of 0.78
million shares was recorded, which was greater than its 150-day
daily average volume of 0.68 million shares. Over the last five
days, Abiomed Inc's shares have declined by 8.71% while in the past
one month, it has gained a momentum of 1.31%. Additionally, over
the last three months, the stock has advanced 42.49% and in the
past six months, the shares have registered a profit of 35.27%.
Further, the company is trading at a price to earnings ratio of
33.61 and a price to book ratio of 12.97. This compares to a
historical PE ratio of 26.98. The historical PB ratio is near to
10.15. Further, the stock is trading at a price to cash flow ratio
of 61.68 and price to sales ratio of 15.68. Register for free on
ACI Association and access the latest research on ABMD at:
http://www.aciassociation.com/ABMD.pdf
--
CytRx Corp
--
CytRx Corp's stock decreased by 9.75% to close Friday's session
at USD 2.50. The company's shares
fluctuated in the range of USD 2.49
and USD 2.86. A total of 0.78 million
shares exchanged hands, which was lesser than its 50-day daily
average volume of 0.94 million shares. Over the last three days
CytRx Corp's shares have declined by 8.76% and in the past one week
it has moved down 12.28%. Furthermore, over the last three months,
the stock has lost 33.51% and in the past six months, the shares
have shed 23.78%. The stock is at a price to book ratio of 3.29.
The historical PB ratio is near to 2.25. The complete research on
CYTR is available for free at:
http://www.aciassociation.com/CYTR.pdf
--
Dynavax Technologies Corp
--
Dynavax Technologies Corp's stock slipped by 4.60% to close
Friday's session at USD 26.54. The
company's shares oscillated between USD
25.75 and USD 28.29. The stock recorded a trading volume of
0.77 million shares, which was above its 50-day daily average
volume of 0.61 million shares. Over the last five days, Dynavax
Technologies Corp's shares have declined by 13.92% and in the past
one month, it has gained a momentum of 3.96%. In addition, over the
last three months, the stock has gained 18.75% and year to date,
the shares have picked up 57.41%. The stock is at a price to book
ratio of 10.77. The historical PB ratio is near to 4.41.
Additionally, the stock is trading at a price to sales ratio of
152.97. Free in-depth research on DVAX is available at:
http://www.aciassociation.com/DVAX.pdf
--
EnteroMedics Inc
--
EnteroMedics Inc's stock declined 2.65% to close Friday's
session at USD 0.25. The share price
vacillated between USD 0.25 and USD
0.27. The stock recorded a trading volume of 0.74 million
shares, which was below its 50-day daily average volume of 1.23
million shares and below its 52-week average volume of 0.94 million
shares. Over the last three days, EnteroMedics Inc's shares have
declined by 4.85% and in the past one week it has moved down
12.72%. Moreover, in the last six months, the stock has lost 73.64%
and year to date, the shares have shed 82.18%. The stock is at a
price to book ratio of 13.15. The historical PB ratio is near to
14.82. Additionally, the stock is trading at a price to sales ratio
of 340.90. The complimentary notes on ETRM can be downloaded in PDF
format at:
http://www.aciassociation.com/ETRM.pdf
--
About ACI Association:
Active Charter Investors Association ("ACI Association")
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
equities listed on NYSE and NASDAQ and micro-cap stocks. ACI
Association has two distinct and independent departments. One
department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ACI Association has not been compensated; directly or
indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein. The information in this release has been
sourced from a third party data base.
NO WARRANTY
ACI Association, the Author, the Reviewer and the Sponsor
(collectively referred to as the "Publishers") are not responsible
for any error which may be occasioned at the time of printing of
this document or any error, mistake or shortcoming. No liability is
accepted by the Publishers whatsoever for any direct, indirect or
consequential loss arising from the use of this document. The
Publishers expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, the Publishers do not (1) guarantee the accuracy,
timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The
included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ACI Association nor any party affiliated
with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our
report(s), read our disclosures, or for more information, visit
http://www.aciassociation.com/.
RESTRICTIONS
ACI Association is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.aciassociation.com